Search Results

You searched for : Alembic  

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation

Testosterone Topical Solution USP, 30 mg per pump actuation is indicated for replacement therapy in males for conditions associated with a deficiency or absence of ...
Jun 17

Top Ten Pharma Companies of India : January 2021

Top ten pharma stocks January 2021...
Jan 06

Alembic Pharmaceuticals announces USFDA Final Approval for Asenapine Sublingual Tablets

Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults....
Dec 11

Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone Tablets

Metolazone Tablets are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class....
Dec 03

Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone Tablets USP

Alembic has a cumulative total of 137 ANDA approvals (118 final approvals and 19 tentative approvals) from USFDA...
Dec 03

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Testosterone Gel

Testosterone Gel, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone....
Nov 25

Alembic Pharmaceuticals receives USFDA Tentative Approval for Palbociclib Capsules for Breast Cancer

Alembic now has a total of 135 ANDA approvals (117 final approvals and 18 tentative approvals) from USFDA....
Nov 10

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Tavaborole Topical Solution

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Topical Solution, 5%, of Anacor Pharmaceuticals, Inc....
Oct 22

Alembic Pharmaceuticals announces USFDA Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg.

Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg have an estimated market size of US$ 17 million for twelve months ending June 2020 ...
Oct 21

Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets

Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020...
Aug 27

Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

Alembic receives USFDA approval for their erectile dysfunction drug ...
Aug 05

Q4 Net profit up 81% to 225cr by Alembic Pharma

Alembic Pharma reported its unaudited financial results for the fourth quarter and year....
Apr 24

Alembic Pharmaceuticals announces USFDA Final Approval for Bosentan Tablets, 62.5 mg and 125 mg.

New US FDA approval for Alembic...
Jan 25

Alembic Pharmaceuticals Q3 Net Profit up 38% to Rs 234 crores

Alembic Q3 up by 38%...
Jan 23

Alembic Pharmaceuticals receives USFDA Final Approval for Vilazodone Hydrochloride Tablets, 10 mg, 20 mg, and 40 mg.

Alembic scores another ANDA approval from US FDA...
Jan 21

Alembic receives ANDA for for Vilazodone Hydrochloride tablets

Alembic recieves ANDA for Vilazodone Hydrochloride tablets used for the treatment of depression....
Jan 14

Alembic Pharmaceuticals announces , USFDA Approval for Clobetasol Propionate Spray, 0.05%

Alembic Pharmaceuticals Limited has received approval from. the US Food & Drug Administration (USFDA) for Clobetasol Propionate Spray, 0.05%....
Oct 23

17 Matching result(s) found!

-Advertisements-



Trending Now

How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026